Telehealth Autism Assessment During & Post-COVID-19

Telehealth Autism Assessment During & Post COVID-19: No-Cost Webinar Organized by


Please support’s ability to deliver helpful news, opinions, and analyses by turning off your ad blocker.

San Diego – A webinar entitled Telehealth Autism Assessment During & Post-COVID-19 is sponsored by Behavior Imaging Solutions on March 14, at 12 PM Eastern (9 AM Pacific). The webinar faculty will feature Catherine Lord, Ph.D., Distinguished Professor of Psychiatry and Education, University of California, Los Angeles; Michael Morrier, Ph.D., BCBA-D, Associate Professor, Emory University School of Medicine; Allison Schwartz, Ph.D., Assistant Professor, Emory University School of Medicine; and Christopher J. Smith, Ph.D. Chief Science Officer, Southwest Autism Research and Resource Center (SARRC). The event is being hosted by and will be moderated by Marlene M. Maheu, Ph.D.

The webinar is geared for clinicians who have experience evaluating and diagnosing children with autism but may not have had exposure to newer telehealth platforms that further enable their clinical activities. By attending this webinar, clinicians will hear from industry-leading autism clinical researchers who have been using telehealth to facilitate remote autism assessment with children under the age of seven. The webinar will also reference some research that helps validate the use of telehealth, plus practice management issues, including reimbursement. Future directions include using telehealth for co-morbidities and diagnosing and treatment support for older people. 

Learning Objectives

Attendees will be able to:

  • Describe evidence-based asynchronous and synchronous methods for telehealth autism evaluation in young children to gather evidence and facilitate reporting.
  • Describe how to incorporate autism screeners, in-person interactions, and parent-report assessment instruments into a telehealth assessment with children to elicit desired behaviors to test at home.
  • Describe how the NODA (Naturalistic Observation Diagnostic Assessment) can be used in a clinic’s diagnostic services.
  • Examine the implications of doing telehealth autism assessments with older patients.

The 1-hour webinar is intended for professionals familiar with autism assessment who want to add or improve telehealth autism assessment in their practice. They will learn about assessment instruments used, including BOSCC, BOSA, NODA, and innovations in real-time telehealth that facilitate remote autism diagnosis.


This free telehealth autism assessment event is available to the professional community only. Research reported in this webinar was supported by the National Institute of Mental Health under Award Number 5R44MH112470. The content is solely the authors’ responsibility and does not necessarily represent the official views of the National Institutes of Health.


To register for this training and get proof of attendance at no cost, go to Telehealth Autism Assessment During & Post-COVID-19.

Behavior Imaging Solutions

Behavior Imaging(R) (BI) develops telehealth, imaging, and digital health solutions that lead to earlier diagnosis and better treatment options for various behavioral health and special education conditions. The company’s unique real-time telehealth utility and revolutionary ‘EHR-light’ video platforms enable remote health and education assessments to improve clinical trial coordination. BI leads multiple research studies on NODA™ (Naturalistic Observation Diagnostic Assessment), BI’s remote autism diagnostic assessment platform for experienced clinicians. For more information, visit or was the first and continues to be the leading interprofessional telehealth training institute worldwide, offering CME and CE training and consultation through the many innovative and customizable programs offered by is available to host, moderate, and publicize telehealth-related digital training events using 22nd Century digital marketing techniques. For details, visit For more information, contact

Disclaimer: offers information as educational material designed to inform you of issues, products, or services potentially of interest. We cannot and do not accept liability for your decisions regarding any information offered. Please conduct your due diligence before taking action. Also, the views and opinions expressed are not intended to malign any organization, company, or individual. Product names, logos, brands, and other trademarks or images are the property of their respective trademark holders. There is no affiliation, sponsorship, or partnership suggested by using these brands unless contained in an ad. We do not and cannot offer legal, ethical, billing technical, medical, or therapeutic advice. Use of this site constitutes your agreement to Privacy Policy and Terms and Conditions.